InsidersTradesSigma
Track the 휴메딕스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 휴메딕스 has published 2 insider filings. Market capitalisation: €269.8bn. The latest transaction was disclosed on 27 April 2026 (Purchase). Among the most active insiders: 휴온스글로벌. All data is openly available.
2
Insider Decl.
n/a
Thresholds
€115,434
2 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 485 of 29,063 companies
84.8
score / 100
Value93
Quality76
FCF yld13%
Earn yld19%
EV/EBITDA3.7x
ROE7.3%
Gross mgn47%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 April 2026
Acerca de 휴메딕스
Humedics es una empresa especializada en el sector de la salud y farmacéutico, cotizada en la bolsa XKRX. Se enfoca en el desarrollo de productos médicos innovadores.